| Kristopher Wayne Whitehead, MD | |
|
499 Gloster Creek Vlg, Suite A1, Tupelo, MS 38801-4600 | |
| (662) 377-7100 | |
| (662) 377-7115 |
| Full Name | Kristopher Wayne Whitehead |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 19 Years |
| Location | 499 Gloster Creek Vlg, Tupelo, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700057106 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 21047 (Mississippi) | Primary |
| 208800000X | Urology | ME96599 (Florida) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thomas Hospital | Fairhope, AL | Hospital |
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| Singing River Health System | Pascagoula, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Associates Of Mobile, P.a. | 3870497951 | 49 |
News Archive
ResApp Health Limited, announced today a positive outcome from its recent Pre-Submission Meeting with the United States Food and Drug Administration (FDA) regarding ResApp's diagnostic mobile software application, ResAppDx.
Synthetic Biologics, Inc., a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, reported the initiation of a Phase 2 clinical trial of its proprietary SYN-010 for the treatment of irritable bowel syndrome with constipation (IBS-C).
SunLink Health Systems, Inc.(the "Company") today announced that in view of the unusual activity in the Company's stock, the New York Stock Exchange (NYSE) has contacted the Company in accordance with the NYSE's usual practice and requested that the Company respond by news release to the unusual activity.
Pioglitazone, a medication approved for treatment of type 2 diabetes, can help bypass genetic defects in chronic granulomatous disease to help white blood cells fight bacterial infections, according to researchers at National Jewish Health.
› Verified 5 days ago
| Entity Name | Urology Associates Of Mobile, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194828368 PECOS PAC ID: 3870497951 Enrollment ID: O20031120000743 |
News Archive
ResApp Health Limited, announced today a positive outcome from its recent Pre-Submission Meeting with the United States Food and Drug Administration (FDA) regarding ResApp's diagnostic mobile software application, ResAppDx.
Synthetic Biologics, Inc., a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, reported the initiation of a Phase 2 clinical trial of its proprietary SYN-010 for the treatment of irritable bowel syndrome with constipation (IBS-C).
SunLink Health Systems, Inc.(the "Company") today announced that in view of the unusual activity in the Company's stock, the New York Stock Exchange (NYSE) has contacted the Company in accordance with the NYSE's usual practice and requested that the Company respond by news release to the unusual activity.
Pioglitazone, a medication approved for treatment of type 2 diabetes, can help bypass genetic defects in chronic granulomatous disease to help white blood cells fight bacterial infections, according to researchers at National Jewish Health.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristopher Wayne Whitehead, MD Po Box 829, Tupelo, MS 38802-0829 Ph: (662) 377-7100 | Kristopher Wayne Whitehead, MD 499 Gloster Creek Vlg, Suite A1, Tupelo, MS 38801-4600 Ph: (662) 377-7100 |
News Archive
ResApp Health Limited, announced today a positive outcome from its recent Pre-Submission Meeting with the United States Food and Drug Administration (FDA) regarding ResApp's diagnostic mobile software application, ResAppDx.
Synthetic Biologics, Inc., a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, reported the initiation of a Phase 2 clinical trial of its proprietary SYN-010 for the treatment of irritable bowel syndrome with constipation (IBS-C).
SunLink Health Systems, Inc.(the "Company") today announced that in view of the unusual activity in the Company's stock, the New York Stock Exchange (NYSE) has contacted the Company in accordance with the NYSE's usual practice and requested that the Company respond by news release to the unusual activity.
Pioglitazone, a medication approved for treatment of type 2 diabetes, can help bypass genetic defects in chronic granulomatous disease to help white blood cells fight bacterial infections, according to researchers at National Jewish Health.
› Verified 5 days ago
Katelynn Pannell, NP Urology Medicare: Accepting Medicare Assignments Practice Location: 499 S Gloster St Ste A-1, Tupelo, MS 38801 Phone: 662-432-0700 | |
Dr. Jon T Posey, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 499 Gloster Creek Vlg, Suite A1, Tupelo, MS 38801 Phone: 662-377-7100 | |
Dr. Jonathan Kalish, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 499 Gloster Creek Vlg, Suite A1, Tupelo, MS 38801 Phone: 662-377-7100 Fax: 662-377-7115 | |
Jeremy Scott Archer, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 499 Gloster Creek Vlg Ste A1, Tupelo, MS 38801 Phone: 662-432-0700 | |
Dr. Clarance Stephen Farmer Ii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 499 Gloster Creek Vlg, Suite A1, Tupelo, MS 38801 Phone: 662-377-7100 Fax: 662-377-7115 | |
Dr. Paul Farabaugh, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 499 Gloster Creek Vlg, Suite A1, Tupelo, MS 38801 Phone: 662-377-7100 Fax: 662-377-7115 |